Merck & Co bolsters hepatitis C pipeline with Idenix acquisition

Thursday, June 12, 2014 - 03:32 in Health & Medicine

Early-stage drugs complement Merck’s own developmental portfolio

Read the whole article on Chemistry World

Get the latest and most popular science news articles of the week in your Inbox! It's free!